These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Office Treatment of Migraine in 2004]. Göbel H; Heinze A MMW Fortschr Med; 2004 May; 146 Spec No 2():31-2, 34, 36 passim. PubMed ID: 15376699 [TBL] [Abstract][Full Text] [Related]
25. Medical Treatment Guidelines for Acute Migraine Attacks. Hsu YC; Lin KC; Taiwan Headache Society TGSOTHS Acta Neurol Taiwan; 2017 Jun; 26(2):78-96. PubMed ID: 29250761 [TBL] [Abstract][Full Text] [Related]
26. How general practitioners treat migraine patients: evaluation of a headache guideline. Zielman R; Veenstra P; Zwet Ev; Berg Jv Cephalalgia; 2012 Sep; 32(12):908-15. PubMed ID: 22843226 [TBL] [Abstract][Full Text] [Related]
27. Drugs for Migraine. Med Lett Drugs Ther; 2020 Oct; 62(1608):153-160. PubMed ID: 33434187 [No Abstract] [Full Text] [Related]
28. Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine. Kouremenos E; Arvaniti C; Constantinidis TS; Giannouli E; Fakas N; Kalamatas T; Kararizou E; Naoumis D; Mitsikostas DD; J Headache Pain; 2019 Dec; 20(1):113. PubMed ID: 31835997 [TBL] [Abstract][Full Text] [Related]
29. Practical considerations for the treatment of elderly patients with migraine. Sarchielli P; Mancini ML; Calabresi P Drugs Aging; 2006; 23(6):461-89. PubMed ID: 16872231 [TBL] [Abstract][Full Text] [Related]
30. Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Affaitati G; Martelletti P; Lopopolo M; Tana C; Massimini F; Cipollone F; Lapenna D; Giamberardino MA; Costantini R Pain Pract; 2017 Mar; 17(3):392-401. PubMed ID: 27207273 [TBL] [Abstract][Full Text] [Related]
31. A 3-month analysis of disability, quality of life, and disease course in patients with migraine. Raggi A; Leonardi M; Bussone G; D'Amico D Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760 [TBL] [Abstract][Full Text] [Related]
33. Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres. Cevoli S; D'Amico D; Martelletti P; Valguarnera F; Del Bene E; De Simone R; Sarchielli P; Narbone M; Testa L; Genco S; Bussone G; Cortelli P Cephalalgia; 2009 Dec; 29(12):1285-93. PubMed ID: 19438916 [TBL] [Abstract][Full Text] [Related]
34. [Prophylactic treatment of migraine]. Igarashi H Nihon Rinsho; 2005 Oct; 63(10):1809-14. PubMed ID: 16218395 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Blumenfeld A; Gennings C; Cady R Headache; 2012 Apr; 52(4):636-47. PubMed ID: 22221151 [TBL] [Abstract][Full Text] [Related]
36. Initiating and optimizing acute therapy for migraine: the role of patient-centered stratified care. Diamond M; Cady R Am J Med; 2005 Mar; 118 Suppl 1():18S-27S. PubMed ID: 15841884 [TBL] [Abstract][Full Text] [Related]
37. Traditional and Novel Migraine Therapy in the Aging Population. Mathew S; Ailani J Curr Pain Headache Rep; 2019 May; 23(6):42. PubMed ID: 31079259 [TBL] [Abstract][Full Text] [Related]
38. [Treatment of migraine: analgetic plus antiemetic or tryptan]. Göbel H MMW Fortschr Med; 2003 May; 145 Suppl 2():72-8. PubMed ID: 14579489 [TBL] [Abstract][Full Text] [Related]
39. Postmarketing migraine survey of frovatriptan: effectiveness and tolerability vs previous triptans, NSAIDs or a combination. Cady RK; Banks J; Jones BA; Campbell J Curr Med Res Opin; 2009 Nov; 25(11):2711-21. PubMed ID: 19778164 [TBL] [Abstract][Full Text] [Related]